Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 13, 2010 FORM 8-K
4 Sep 8, 2010 MAIN DOCUMENT DESCRIPTION
4 Sep 8, 2010 MAIN DOCUMENT DESCRIPTION
4 Sep 7, 2010 MAIN DOCUMENT DESCRIPTION
3 Sep 7, 2010 MAIN DOCUMENT DESCRIPTION
8-K Sep 7, 2010 FORM 8-K
8-K Aug 30, 2010 FORM 8-K
8-K Aug 16, 2010 FORM 8-K
4 Aug 9, 2010 MAIN DOCUMENT DESCRIPTION
10-Q Aug 5, 2010 FORM 10-Q
8-K Jul 13, 2010 FORM 8-K
8-K Jul 12, 2010 FORM 8-K
4 Jun 23, 2010 MAIN DOCUMENT DESCRIPTION
8-K Jun 8, 2010 FORM 8-K
8-K May 18, 2010 FORM 8-K
10-Q May 10, 2010 FORM 10-Q
4 May 3, 2010 MAIN DOCUMENT DESCRIPTION
8-K Apr 27, 2010 FORM 8-K
4 Apr 16, 2010 MAIN DOCUMENT DESCRIPTION
4 Mar 25, 2010 MAIN DOCUMENT DESCRIPTION
8-K Mar 17, 2010 FORM 8-K
CT ORDER Mar 15, 2010
8-K Mar 9, 2010 FORM 8-K
8-K Mar 3, 2010 FORM 8-K
4 Feb 26, 2010 MAIN DOCUMENT DESCRIPTION
← Newer Page 27 of 38 · 935 filings Older →